Status:
COMPLETED
Three Protocols for Phenylephrine Administration in Cesarean Delivery
Lead Sponsor:
Cairo University
Conditions:
Cesarean Section Complications
Spinal Anesthesia
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
The investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single...
Detailed Description
Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Phenylephrine (PE) is the most popular vasopressor for prevention of post-spinal hypotension (PSH) dur...
Eligibility Criteria
Inclusion
- Full term
- Pregnant women
- Scheduled for cesarean delivery
Exclusion
- Pre-eclampsia
- Eclampsia
- Hemorrhage
- Cardiac dysfunction
- Baseline low heart rate (below 60 bpm)
Key Trial Info
Start Date :
October 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2018
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT03302039
Start Date
October 6 2017
End Date
October 15 2018
Last Update
December 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt